
Nvidia reported fiscal Q1 revenue of $81.6 billion, up 85% year over year, with non-GAAP EPS of $1.87, up 140%, and guided to $91 billion in current-quarter revenue, implying 95% growth. The article argues Nvidia's AI inference and data center demand remain strong, with management citing Vera Rubin racks delivering up to 35x higher inference throughput and targeting $1 trillion of revenue from Blackwell and Rubin chips in 2026-2027. It also points to analysts lifting estimates and a potential path to a $15 trillion market cap within three years.
The key takeaway is not that NVDA is still growing, but that its growth curve is re-accelerating at a scale that forces ecosystem participants to stay inside its architecture longer than the market expected. That matters because inference is the wedge where custom silicon was supposed to erode GPU share, yet NVDA is converting inference from a cost-minimization problem into a systems-performance problem by bundling rack-scale throughput, software, and deployment velocity. The second-order effect is that hyperscalers may keep diversifying at the margin, but budget allocation still skews toward the vendor that compresses time-to-scale, which supports capex concentration and preserves NVDA's pricing power. The more interesting implication is for the rest of the AI supply chain. If NVDA wins more of the inference stack, demand pressure extends to advanced packaging, HBM, substrates, and high-end networking rather than just wafers; that keeps the bottleneck in the “picks and shovels” layer and leaves potential for periodic supply snarls to amplify revenue visibility. For INTC, the article is a reminder that foundry and custom-ASIC narratives can coexist with a dominant accelerator franchise, but it also means the window for Intel to displace meaningful AI workloads remains narrow unless it can prove a materially lower total-cost-of-inference solution. The consensus may be underestimating how much of the upside is already embedded in the name, but also underestimating how long the multiple can stay elevated if earnings revisions keep outrunning price. The main reversal risk is not competition; it is a capex digestion phase in 6-12 months where hyperscalers pause orders after overbuilding 2025-26 capacity, or any evidence that inference workloads shift more aggressively to lower-cost custom silicon than current deployment trends suggest. In that scenario, the stock can still compound, but the beta to guidance will likely compress sharply even if fundamentals remain strong. Near term, this is more of a duration-and-positioning trade than a pure fundamentals trade: crowded long ownership plus ongoing estimate raises can keep the tape strong, but the asymmetry worsens if growth decelerates even modestly from these levels. The higher-probability setup is to own NVDA through any post-print digestion while pairing it against names exposed to lost AI wallet share or against broader semiconductor baskets that lack the same earnings revision momentum.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request DemoOverall Sentiment
strongly positive
Sentiment Score
0.78
Ticker Sentiment